Article Text


Extracellular ATP in asthma airway inflammation
  1. D Parekh
  1. D Parekh, Medical SHO/ST2, Birmingham Heartlands Hospital, UK; dhruvey{at}

Statistics from

A role for ATP as a pro-asthmatic mediator has previously been suggested from in vitro studies. This group investigated whether extracellular ATP and purinergic signalling are important mediators of airway inflammation in asthma, using experimental mice models and human subjects.

Rapid accumulation of ATP was observed in bronchoalveolar lavage (BAL) fluid after allergen challenge in subjects with allergic asthma and in experimentally sensitised mice. In the mouse model, ATP binding to purinergic receptors drove inflammatory chemotaxis and bronchospasm. Prevention of this increase in ATP using treatment with the ATP-hydrolysing enzyme apyrase to degrade ATP, or blockade of ATP effects using broad spectrum purinergic P2 receptor antagonists, down modulated all of the cardinal features of the asthmatic response. In addition, administration of exogenous ATP to mice enhanced Th2-type sensitisation to inhaled antigen, indicating that ATP may contribute to the development of asthmatic sensitisation by recruitment of Th2-inducing lung myeloid dendritic cells to mediastinal lymph nodes.

The authors conclude that ATP and purinergic signalling are important in the pathogenesis of asthma. Further studies are needed, but this may be an important therapeutic target for the future.

Idzko M, Hammad H, van Nimwegen M, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007;13:913–9

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.